These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30694220)

  • 1. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease.
    Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S
    JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
    Matta BM; Reichenbach DK; Zhang X; Mathews L; Koehn BH; Dwyer GK; Lott JM; Uhl FM; Pfeifer D; Feser CJ; Smith MJ; Liu Q; Zeiser R; Blazar BR; Turnquist HR
    Blood; 2016 Jul; 128(3):427-39. PubMed ID: 27222477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB; George TI; Dutt S; Strober S
    Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease.
    Le HT; Keslar K; Nguyen QT; Blazar BR; Hamilton BK; Min B
    Front Immunol; 2020; 11():181. PubMed ID: 32117306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.
    Ganguly S; Ross DB; Panoskaltsis-Mortari A; Kanakry CG; Blazar BR; Levy RB; Luznik L
    Blood; 2014 Sep; 124(13):2131-41. PubMed ID: 25139358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.
    Reichenbach DK; Schwarze V; Matta BM; Tkachev V; Lieberknecht E; Liu Q; Koehn BH; Pfeifer D; Taylor PA; Prinz G; Dierbach H; Stickel N; Beck Y; Warncke M; Junt T; Schmitt-Graeff A; Nakae S; Follo M; Wertheimer T; Schwab L; Devlin J; Watkins SC; Duyster J; Ferrara JL; Turnquist HR; Zeiser R; Blazar BR
    Blood; 2015 May; 125(20):3183-92. PubMed ID: 25814531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
    Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
    Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ST2
    Wachtendorf S; Jonin F; Ochel A; Heinrich F; Westendorf AM; Tiegs G; Neumann K
    Front Immunol; 2024; 15():1351405. PubMed ID: 38571949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very Low Numbers of CD4
    Copsel S; Wolf D; Kale B; Barreras H; Lightbourn CO; Bader CS; Alperstein W; Altman NH; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1788-1794. PubMed ID: 29751114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.
    Belle L; Agle K; Zhou V; Yin-Yuan C; Komorowski R; Eastwood D; Logan B; Sun J; Ghilardi N; Cua D; Williams CB; Gaignage M; Marillier R; van Snick J; Drobyski WR
    Blood; 2016 Oct; 128(16):2068-2082. PubMed ID: 27488350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.
    Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB
    Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.
    Li Y; Guan X; Liu W; Chen HL; Truscott J; Beyatli S; Metwali A; Weiner GJ; Zavazava N; Blumberg RS; Urban JF; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2018 Nov; 201(10):2910-2922. PubMed ID: 30291167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Fanca or Fancd2 dysregulates Treg in mice.
    Du W; Erden O; Wilson A; Sipple JM; Schick J; Mehta P; Myers KC; Steinbrecher KA; Davies SM; Pang Q
    Blood; 2014 Mar; 123(12):1938-47. PubMed ID: 24501220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
    Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR
    J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.